Fordham University
Masthead Logo

DigitalResearch@Fordham

Chemistry Faculty Publications

Chemistry

1964

Quantitative aspects of CO2 fixation in
mammalian brain in vivo / H. Waelsch, S. Berl, C.A.
Rossi, D. D. Clarke, and D. P. Purpura New York
State Psychiatric Institute and Departments of
Biochemistry and Neurological Surgery, College of
Physicians and Surgeons, Columbia University,
New York, N.Y.
Heinrich Waelsch
New York State Psychiatric Institute

Soll Berl
Columbia University. College of Physicians and Surgeons

C. A. Rossi
Università di Pisa

Donald Dudley Clarke PhD
Fordham
University,
clarke@fordham.edu
Follow this
and additional
works at: https://fordham.bepress.com/chem_facultypubs

Part of the Biochemistry Commons
Recommended Citation
Waelsch, Heinrich; Berl, Soll; Rossi, C. A.; and Clarke, Donald Dudley PhD, "Quantitative aspects of CO2 fixation in mammalian
brain in vivo / H. Waelsch, S. Berl, C.A. Rossi, D. D. Clarke, and D. P. Purpura New York State Psychiatric Institute and Departments
of Biochemistry and Neurological Surgery, College of Physicians and Surgeons, Columbia University, New York, N.Y." (1964).
Chemistry Faculty Publications. 77.
https://fordham.bepress.com/chem_facultypubs/77

This Article is brought to you for free and open access by the Chemistry at DigitalResearch@Fordham. It has been accepted for inclusion in Chemistry
Faculty Publications by an authorized administrator of DigitalResearch@Fordham. For more information, please contact considine@fordham.edu.

Journal of Neurochemistry. 1964. Vol. 11, pp. 7 J 7 to 728. Pergamon Press Ltd. Printed in Northern Ireland

QUANTITATIVE ASPECTS OF C0 2 FIXATION IN
MAMMALIAN BRAIN IN VIVO*
H. WAELSCH, S. BERL t, C. A. Rossrt, D. D. CLARKE and D. P. PURPURA§
New York State Psychiatric Institute and Departments of Biochemistry and
Neurological Surgery, College of Physicians and Surgeons, Columbia University
New York, N.Y.
(Received 22 January 1964)

RECENTLY, a significant fixation of carbon dioxide into aspartic and glutamic acids
and glutamine, isolated from the protein-free filtrate of brain cortex of the cat, was
shown after intravenous infusion of NaH 14C03 in vivo (W AI:LSCH, BERL, TAKAGAKI,
CLARKE and PURPURA, 1961; BERL eta/., l962b). In accord with the prevailing view
as to the mechanism of C02 fixation, the isolated aspartic acid showed the highest
specific activity of the amino acids analysed. On simultaneous infusion of ammonium
acetate, the specific activity of glutamine increased relative to that of aspartic acid,
a finding which suggested that the increased glutamine synthesis resulting from the
elevated tissue arntnonia level leads to a preferential utilization of oxaloacetate in
the direction of oxoglutarate. This finding raised the question whether the increased
radioactivity of glutamine in the presence of elevated ammonia levels was a result of
a net increase in the rate of C02 fixation or whether we were dealjng with a redistribution of 14C-carbon atoms. The operation of C02 fixation adapted to the
metabolic needs of nervous tissue may introduce another factor controlling the rate
of the citric acid cycle and n1ay be of significance in linking metabolism and function.
Support for a possible general role of C02 fixation in the nervous system may be
seen in the demonstration of its occurrence in the nerves of the lobster and the sciatic
nerve of the frog (CHENG and W AELSCH, 1962, ] 963; COTE, CHENG and WAELSCIJ, in
preparation). These findings taken together suggest the general occurrence of C02
fixation in nervous tissue throughout the animal kingdom. It was also found that
the C02 fixation into glutamic and aspartic acids in lobster nerve was greatly inhibited
in the presence of 0·4 M-ouabain or in the absence of sodium, conditions which affect
the ionic movement and the transmission of impulses in the nerve (CHENG and
WAELSCH, 1963).
To obtain a better picture of the quantitative significance of C02 fixation in
nervous tissue, a study was undertaken of the rate of C02 fixation from tissue C02

* Preliminary reports of some of the findings have been made, Rossr, BERL, CLARKE, PuRPURA
and WAELSCH (1962).
This work was supported in part by grants from the National Institute of Neurological Diseases
and Blindness (B-557, NB-04064-01 t and NB-01312-07§), by Public Health Service Research
Career Program, National Institute of Neurological Diseases and Blindness (NB-K3-5117-0l t and
5-K3-NB-5280-03§), by the Supreme Council, 33° Scottish Rite Masons of the Northern Jurisdiction, United States of America, and the United States Air Force Office of Scientific Research.
tOn leave of absence from the Department of Biochemistry, University of Pisa, Pisa, Italy.
Abbreviations used: tris, tris (hydroxymethyl) aminomethane; PPO, 2,5-diphenyloxazole; POPOP,
2,2-p-phenylenebis (5-phenyJoxazoJe).
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into the metabolites of the protein-free filtrates of brain cortex and liver and particularly into aspartic and glutamic acids and glutamine in the presence of elevated
tissue ammonia.
EXPERIMENTAL
In the experiments previously reported both NaH14 C0 3 and ammonium acetate were infused
throughout the experiment into the carotid artery of cats for periods of 8-25 n1in (BERL et al., 1962a,
b). These procedures were selected in order to n1aintain a high concentration of the isotope until the
end of the experiment and to avoid the difficulties of interpretation entailed in single pulse labelling.
The requirements for the maintenance of a steady state level of HC0 2 in the experiments reported
in this paper made a modification of the original procedure necessary (Rossi, BERL, CLARKE, PuRPURA and W AELSCR, 1962). The one finally adopted after various trials was the infusion of NaH14 C0 3
into the inferior vena cava through a cannula inserted into the femoral vein of the cat paralysed by
succinylcholine and anaesthetized locally (PURPURA and GRUNDFEST, 1957). The infusion into the
vena cava facilitated the maintenance of a steady state and made possible a more valid comparison of
brain and liver data.
A n1ajor part (1·7 ml) of the bicarbonate solution (0·06 M, 0·29 mcfml in saline) was given
during the first 10 sec to bring the specific activity of blood C02 rapidly to a precalculated level.
Infusion was continued at the rate of 0·2 ml/min (Harvard Constant Infusion Pump) to maintain
blood C02 at a constant specific activity. Arterial and venous blood were sampled at 1-2 min intervals throughout the experiment by the capillary tube collecting method (NATELSON 1951) through
cannulae placed into the right common carotid and the longitudinal sinus of the brain. With the
infusion still in progress, brain cortex and liver were removed and frozen in liquid nitrogen.
The ammonium acetate was administered as a 2·5 M solution containing NaH14C0 3 (0·06 M;
0·29 mc/ ml). This solution was infused at a rate of 0·2 ml/min immediately following the rapid
injection of the 1·7 ml of the NaHC03 solution.
During the first such experiment in which ammonium acetate was administered, the concentration of blood C02 decreased approximately 3 ,umoles/ml (Table 1, Exp. 22; Fig. 1) with a corresponding rise in the specific activity of C02, since during the infusion the administered labelled
TABLE 1.-CONCENTRATION AND SPECIFIC ACTIVITY OF PLASMA 14 C02

Arterial
,umoles/ml
Exper. Duration
(min) average
no.

Venous

counts/ min/pmole

ttmoles/ ml

counts/min/ ~tmole

range

average

range

average

range

average

range

26,40032,400
34,00038,400
38,10041,200
42,50054,200
58,20063,300
53,80087,000
34,40046,300
37,60056,400
22,40029,200
19,40022,500

20·2

19·6-21·3

23,900

20·1

19·7-20·5

31,800

19·5

18·8-20·2

36,700

22·0

20·9- 22·9

45,100

19·2

18·7- 19·9

50,300

16·7

16·0-17·6

52,900

23·8

23·4-24·2

34,500

20·9

20·3-22·0

37,300

23·0

22·3-23·7

21,000

22·4

21·9- 23·0

19,300

21,20027,700
29,20033,700
36,20037,200
39,90049,500
46,600
56,300
43,50061,700
31,50037,800
32,10044,800
18,70024,100
17,90020,300

17t

17·5

15·4

14·8- 16·0

30,100

18

18

17·5

17·0-19·2

36,900

19

4·5

18·2

18·1-18·2

38,500

20

8·5

19·9

19·4-20·5

49,500

21

3·5

16·6

15·5- 16·8

59,900

22*t

15·5

12·5

11·5-13·9

69,600

23*

16

21·5

20·9-22·3

40,600

24

17

17·9

17·4-18·5

45,400

25

16

20·4

19·8-21·2

25,600

26*

16

19·9

19·6-20·3

21,400

For experiments 17, 18, 22 to 26, the values are given for the last 10 min.
* Received ammonium acetate in addition to bicarbonate.
t Experiment 22, see text.
t 0·03 M-NaH 14C0 3(0·145 mcjm1)
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bicarbonate was diluted by a diminishing pool of blood C0 2 • To compensate for this loss of C02
additional unlabelled sodium bicarbonate was added to the ammonium acetate solution. The
calculations were based on the loss of 3 p.moles of C02/ml of blood and a blood content equal to
8 per cent of the animal's body weight (Table 1, Exp. 23 and 26; Fig. 2, Exp. 26).
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FIG. 1.- Concentration and specific activity of carbon dioxide in arterial and venous
blood during infusion of NaH14 C0 3 and ammonium acetate.
Determination of C02 and its specific activity in blood and tissue. Blood C02 was determined by
the method of NATELSON (1951). For the determination of C02 in brain and liver this method was
modified. Samples of frozen brain cortex and liver tissue were we1ghed, and homogenized in an ice
bath under nitrogen in 2 volumes of 0·1 M-tris containing 0·1 M NaF. This was achieved by homogenization in a Potter-Elvehjem all glass homogenizer in a polyethylene bag inflated by a constant
flow of nitrogen . Carbon dioxide-free water was used throughout the determinations, and the reagents were stored with appropriate precautions. The homogenate was centrifuged a t 15,000 gat oo
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in capped tubes filled with N 2 • Whereas in the determination of C02 in blood, 0·03 ml of plasma and
0·1 rnl of 0·5 % low foam detergent were used, the lower C02 concentration in the diluted extracts
from tissue required the use of 0·1 ml of the extract and 0·03 ml of 1·7 % solution of low foam detergent in the NATELSON microgasometer. At the end of the determination the alkaline solution was
transferred quantitatively from the microgasometer to the VAN SLYKE-FOLCH (1940) apparatus with
two washings of C02 - free water; C02 was liberated with lactic acid and absorbed into 0·2 ml of
phenylethylan1ine (WoELLER, 1961). The solution was transferred quantitatively into polyethylene
vials with 10 ml of toluene--ethanol (7·75: 2·25vfv containing 0·5 per cent PPO and 0·01 per cent
POPOP). The radioactivity was measured in a Tri-Carb scintillation spectrometer.
The determination o_ftissue constituents. The isolation and determination of glutamic and aspartic
acids and of glutamine as well as of ammonia were carried out as descdbed previously (BERL eta/.,
1962a). For the isolation of ketoacids in Experiments 17-21, a portion of frozen tissue powder was
treated with a solution of 2,4-dinitrophenylhydrazine (0·1% in 2 N-HCl) (method 1), while in Experiments 22-26 the tissue was treated first with 5 % perchloric acid (4 ml/g of tissue), the suspension
centrifuged, and hydraziDe reagent added to the supernatant (method 2) (ARONOFF 1956). The latter
method provided a reliable deproteinization of the extracts, and fewer bands were found by thin layer
chromatography. The hydrazones of oxoglutarate and pyruvate were isolated and separated by thin
layer chromatography (STAHL, 1956). The plate was developed twice with benzene: ethylacetate
(95: 5) to remove the excess reagent, and twice with benzene: ethylacetate: forn1ic acid (71 :25: 4).
The hydrazones were eluted from the silicic acid with 75% ethanol containing 10% ammonia, and
their concentrations determined spectrophotometrically (380 m,u). It is probable that the samples of
pyruvate isolated were contaminated by pyruvate derived from oxaloacetate decarboxylated during
the isolation procedure. Therefore, the pyruvate values will not be discussed further. As far as the
oxoglutarate samples are concerned it is unlikely that they are contaminated by other keto acids or by
oxoglutarate formed during the procedure of isolation; but there is little doubt that the recovery was
close to quantitative only in a few of the experiments and that, therefore, our data can be used with
confidence only for the values of the specific activity of the oxoglutarate. *
Counting procedures. In all experiments the radioactivities of the amino acids and the hydrazones
were measured at infinite thinness by plating portions on stainless steel planchets (1·25" d) and by
counting in a low background counter (Nuclear Chicago). The radioactivity of blood and tissue
C02 was determined in the scintillation spectrometer as described above.
In Experiments 22-26, the r.1dioactivity of the amino acids was determined by both counting
procedures. For scintillation counting portions of 0·1- 0·2 ml were mixed with 10 ml of the counting
solution described above. In Experiments 22-24 the TCA extracts from tissues were counted also by
both methods; for the scintillation counting the samples were recounted with an internal standard.
The ratio of counts obtained by the two procedures provided a conversion factor which could be
applied when needed (e.g. hydrazones of keto acids). This factor corresponded to 0·44 -+- 0·05 S.D.
(N = 17). In Experiments 17- 21 the TCA extract from tissue was counted only in the low background counter and corrected for self absorption. In the Experiments 20-21 reported in a preliminary
account (Rossi et a!., 1962) an erroneous correction factor was used for correcting specific activity
of the tissue C02 from scintillation to Geiger counting and the seJf absorption factor in the Geiger
counting of TCA extracts was omitted. The values given in this paper (Table 2) therefore supersede
those previously reported.
TABLE 2.-uc INCORPORATION INTO COMPONENTS OF THE NON-PROTEIN FRACTION OF BRAIN CORTEX
DURING NaH14C0 3 INFUSION
17
18
24
Experiment no.
21
19
20
25
3·5
4·5
8·5
17·5
18
17
Duration <min.)
16
counts/min /,~mole (/tmole/ g)
320(9·5)
250(9·0)
840(8·5)
640(8·5)
890(10·2)
1.380(9·9)
500(11·7)
Glutamic acid
570(5·3)
480(5·5)
930(7·6)
770(4·2)
1.640(5·7)
2.440(5·7)
950(6·4)
Glutamine
2,160(3·1)
3.860(2·6)
2.500(2·0)
7,110(2.3)
2.320(2·7)
4.520(2·5)
1,800(2·2)
Aspartic acid
1,090(0·004) 1,770(0.001) 640(0·005)
1,070(0·006) 2,160(0·016) 540(0·015)
730(0·0025)
a-Oxoglutarate
230(0·022)
1.320(0·004) 550(0·030)
820(0·020)
Pyruvate
410(0·006)
1.000(0·063) 70(0·054)
33·0(13·2)
24·0(13·4)
29·0(14·2)
31·0(1 1·0)
50·0(12·3)
22·4(16·2)
Tissue C02 X 1o- 3 40·0(10·8)
In expedmenrs 17-21 all specific activities except those of tissue C0 2 • and in experiments 24 and 25 the specific activities of
the keto acids. were obtained by Geiger counting and are converted for comparative purposes to the equivalent values obtained
by scintillation counting (Factor 0·44, sec text).

* When the hydrazine reagent was

added to a solution of oxoglutarate in perchloric acid, or in
water, and the keto acid isolated as the 2,4 dinitrophenyl hydrazone by thin layer chromatography,
the recoveries varied from 60 to 90 per cent. The recovery of oxoglutarate in Experiments 17- 21
(method 1) was considerably lower than in Experiments 22- 26 (method 2), a result which suggests
that the extraction of keto acids from the tissues by the acid solution of the 2,4 dinitrophenyl hydrazine
is far from complete.

Quantitative aspects of C02 fixation in mammalian brain in vivo

721

RESULTS AND DISCUSSION

One of the aims of the experiments was the comparison of the amount of tissue
C02 incorporated into metabolites in the cortex of the cat brain in vivo in the absence
and presence of an elevated ammonia concentration. Attainment of a steady state of
the specific activity of the tissue C02 was considered desirable to facilitate the interpretation of the results. To achieve this it was attempted to maintain the specific
activities of the arterial and venous carbon dioxide as constant as possible (Table 1).
In the experiments lasting longer than 15 n1in., the range of values for the last 10 min
of the experiments are given; in the short tin1e experjments (19-21) the attainment
TABLE

3.-14C

INCORPORATION INTO COMPONENTS OF THE NON-PROTEIN FRACTION
OF LIVER DURING NaH 14C0 3 INFUSION

Experiment no.
Dura tion(min)
Glutamic acid
Glutamine
Aspartic acid
cx-Oxoglutarate
Pyruvate
Tissue C02 X 1o-a
TCA extract counts/ min/g
tissue X 10- 3
,umoles 14C02 fixed/g tissue

21
3·5

19
4·5

20
8·5

17
17·5

counts/min/pmole (,umole/g.)
11,020(2·2) 6,140(3·4)
10,520(2·7) 11,230(2·0)
2,230(1·5)
1,250(4·4)
2,300(3·0)
1,800(1·5)
34,430(0· 3) 37'700(0· 8) 37'700(0·4) 36,050(0·7)
9,680(0·0025) 2,910(0·002) 16,000(0·001) 2,500(0·02)
500(0·012)
1,090(0·006) 730(0·007)
3,230(0·01)
33·0(14·9)
25·0(14·9)
23·3(16·5)
21-4(15·9)
213·6
8·5

168·1
5·1

415·9
17·8

186-4
8·7

18
18
16,91 0(3 ·4)
5,180(2·8)
43,360(0·7)
6,250(0·004)
1,800(0·005)
25·0(13·4)
327·2
13·0

All values except those for tissue C0 2 converted from Geiger to scintillation counting (see Table 2).
TABLE 4.-14 C INCORPORATION INTO COMPONENTS OF THE NON-PROTEIN FRACTION
OF BRAIN CORTEX DURING NaH 14C0 3 AND AMMONIUM ACETATE INFUSION

Experiment no.
Duration (min)
Glutamic acid
Glutamine
Aspartic acid
cx-Oxoglutarate
Pyruvate
Tissue C0 2 x 1o-s
NH 3

22
15·5

23
16

Counts/min/pmole (jtmoles/g.)
1,520(10·4)
1,320(8·4)
7,860(7·3)
5,370(7·6)
5,900(2·1)
2,330(1· 7)
3,190(0·03)
2,540(0·02)
840(0·14)
1,070(0·06)
55(11 ·4)
38(15·3)
(6·9)
(4·3)

26
16
770(9·4)
3,060(8·1)
2,130(1·8)
930(0·01)
670(0·06)
19(15·0)
(1·8)

Values of specific activities for the keto acids were converted from Geiger to
scintillation counting.

of a steady state could not be expected. A constancy of specific activities of blood C02
was accomplished only in part and, therefore, some variation of the specific activjties
of the tissue C0 2 durjng the experimental period were to be expected. Despite the
variations in specific activities of blood C02 the specific activities of the tissue C02
from brain in Experiments 17, 18, 22-26 lie within the range of the specifiic activities
of the arterial and venous C02 (Tables 1, 2, and 4). In Experiments 19-21 of 3-8 min
duration, the brain values are below the venous values, a finding still more apparent
for the liver values (Table 3)*. This result may be an expression of a lack of equilibration of the tissue C02 with the blood C02 within the experimental period. In

* Since the liver was removed on the average 1 min after the brain, this time delay may have
contributed to the dilution of the specific activity of the liver C0 2 •
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Tables 2, 3, and 4 the data of ten experiments are summarized, seven having been
carried out without, and three with, the simultaneous infusion of ammonium acetate.
Despite the variation in the values of the experiments, certain results common to all
of them stand out. We shall consider first the seven Experiments, (17-21, 24 and 25)
in which only NaH14C03 was infused (Tables 2 and 3). In confirmation of previous
results (BERL et al., 1962b), the specific activity of the aspartic acid of brain cortex
exceeds the specific activities of the glutamic acid and of glutamine. This finding
reinforces the conclusion that C0 2 is being fixed in brain tissue in vh:o at the level of
oxaloacetate or malate. As observed previously, the glutamine of brain cortex has a
higher specific activity than the glutamic acid (BERL et al., I 962b). In liver, ratios
between the specific activities of aspartic and glutamic acids similar to those in brain
are found; however, in this organ the glutamine has a lower specific activity than the
two other an1ino acids.
The specific activities of cerebral aspartic acid reached a level of 6-25 per cent of
those of tissue C02 (Tables 2 and 4). This attests to the significant incorporation
of C02 into oxaloacetate by C02 fixation in the brain. In the liver, the specific
activities of aspartic acid range from 105 per cent of that of tissue C02 in 3- 5 min to
170 per cent in the experiments of 17 and 18 min duration. The rate of labelling of
liver aspartic acid supports the view that C0 2 fixatjon into oxaloacetate in this organ
is a very rapid reaction in vivo and that the fast rate of the 'dicarboxylic acid shuttle'
(TOPPER and HASTINGS, 1949) leads to a specific activity of aspartic acid which may
approach values twice that of the tissue C02 within a short time. The rapid rate of
the shuttle has already been demonstrated in an experiment of 25 min duration
reported previously (BERL et a/., 1962b) in which the two carboxyl groups of liver
aspartic acid showed equal specific activities.
In Experiments 22, 23, and 26 (Table 4) in which ammoni urn acetate and bicarbonate were infused simultaneously, we see the shift of 14C labelling pattern already
described (BERL et a/., 1962b). The specific activities of aspartic acid are still higher
by a factor of 2-4 than those of glutamic acid, but only about two thirds that of
glutamine. This may suggest that in the presence of increased levels of tissue ammonia,
oxaloacetate is preferentially utiljzed in the direction of oxoglutarate for the formation
of glutamic acid to be converted to glutamine. The ratios of specific activities of
aspartic to glutamic acid are only slightly higher in the absence of elevated tissue
ammonia levels in the experiments of longer duration (Tables 2, 4). This relatively
small shift in the ratio is not sufficient to account for the increased incorporation of
14 C into glutamine and hence argues for a net synthesis of oxaloacetate rather than
for a redistribution of counts between aspartic acid and glutamine.
In all experiments glutamic acid has a lower specific activity than glutamine in
brain cortex, a difference accentuated in the presence of ammonia. This result is in
full accord with the conclusion reached previously that glutamine in the brain cortex
is formed from a small compartment of glutamic acid which is metabolically highly
active rather than from the total pool of cerebral glutamic acid (LAJTHA et a!., 1959;
BERL eta!., 196la; 1962a).
The lower specific activity of glutamic acid as compared to that of glutamine even
in the absence of elevated tissue ammonia levels underscores the fact that the
metabolic compartments exist in the absence of a metabolic stress.
Also in accord with previous results is the observation that in liver the specific
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activity of glutailline is considerably lower than that of glutamic acid (Table 3).
From this it has been concluded that liver glutamine is formed from a large compartment, if not the total, of liver glutamic acid . On the other hand, the experiments
with 15N ammonia have shown that in contrast to brain cortex, the a-amino group of
liver aspartic acid exceeds in its 15N content that of liver glutamic acid, a finding
which indicates that liver glutan1ic acid is compartmentalized as far as transamination
with oxaloacetate is concerned.
Since oxoglutaratc serves as a precursor of glutamic acid it would be expected to
have a considerably higher specific activity than glutamic acid and glutamine in brain
and liver. In liver this keto acid has a lower specific activity than glutamic acid in
four of five experiments (Table 3). In the short time experiments (I 9- 21, Table 2) the
specific activity of brain oxoglutarate is 2-4 times that of glutamic acid and up to
twice that of glutatnine. In the experiments of longer duration (Tables 2 and 4) the
specific activity of the keto acid is up to twice that of glutamic acid. In four of seven
experiments the specific activity of the keto acid is not more than 20 per cent higher
than that of the amino acid. In all experiments of longer duration (17, 18, 22- 26) the
specific activity of glutamine exceeds that of the keto acid.
The liver data suggest the existence of a small compartment of labelled oxoglutarate of high specific activity from which glutamic acid is derived. There are two
enzymic mechanisms known by which oxoglutarate may be incorporated into glutamic
acid, namely, by the actions of glutamate dehydrogenase and of transaminases. In
order to explain our results, either of the enzymic systems has to act on a small and
highly labelled compartment of oxoglutarate, but we cannot decide on the basis of
the present experiments which enzymic mechanism operates on this pool. Our
previous results in which glutamic acid and glutamine were labelled by the infusion
of 15N ammonia suggest that the glutamate dehydrogenase is chiefly responsible for
the labelling of the small pool of glutamic acid in the liver (BERL eta!., 1962a).
As in the experiments with 16N ammonia and also in the experiments presented
here, brain glutamine has a higher specific activity than brain glutamic acid in contrast
to the relationship between these compounds in liver. It is apparent also in the
14C0 experiments that the small, but highly labelled, pool of oxoglutarate in brain is
2
used preferentially for the formation ·of glutamic acid which is converted into
glutamine. This finding underscores the analogy of the glutamic acid-glutamine
system in the brain and the glutamic acid-aspartic acid system in the liver as to their
functional similarity for the maintenance of a low level of tissue ammonia in the
respective organs.
In contrast to the findings in liver, the specific activities of oxoglutarate in brain
cortex are slightly higher than or equal to that of glutamic acid. Such a result would
arise if the oxoglutarate would transaminate or would be in isotopic equilibrium
with the major compartment of glutamic acid; this pool of oxoglutarate must be in
contact with the large fraction of the brain glutamic acid probably via soluble
transaminase.
The high specific activity of glutamine relative to that of oxoglutarate can only be
interpreted if one assumes a compartmentation of the oxoglutarate in the cerebral
cortex into at least two pools, one of which must be of very high specific activity.
In this connection it is of interest to get an estimate of the relative turnover rates
of the compounds involved. Data on glucose utilization of the brain are here of
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considerable help; approximately 50 ,umoles of pyruvate are burned per 100 g of
human brain per min. By assuming a metabolic activjty of 5 to 1 for cortex and
white matter, this value would amount to about 0·85 ,umoles/g of cortex/min. To
allow 0·02 ,umoles of oxoglutarate (Tables 2 and 4; cf. KREBS and LoWENSTEIN, 1960)
to channel this amount of pyruvate through the citric acid cycle the total oxoglutarate
would turn over at a rate of 40 tin1es per min. The total concentration of glutamic
acid in cortex is I 0 ,umoles/g from which a minimum of two pools would be derived,
TABLE 5.- TOTAL

14

C02

INCORPORATION INTO THE ?\ON-PROTEIN FRACTION

FROM BRAIN CORTEX

Exp. Duration
(min)
no.
21
19
20
17
18
24
25

3·5
4·5
8·5
17·5
18
17
16

Infusion

NaH14C03

14

22
23
26

15·5
16
16

TCA extract
Tissue 14 COz
3
counts/min/,urn ole x 10 counts/min/g tissue

NaH CO,

+ CH 3 COONH4

{

14

pmole
C0 2/g tissue

40·0
31·0
33·0
24·0
29·0
50·0
22·4

21,930
18,000
48,450
41,360
47,270
115,000
37,900

0·55
0·58
1·47
1·72
1·63
2·30
1·69

55·0
38·0
19·0

142,500
130,200
61,000

2·59*
3·42
3·21

* This result is probably low for reasons explained in the text.

a smaller one (20 per cent of the total!) (BERL et al., 196la) with a half-life time of less
than 60 min and a larger one with a half-life time of 6- 8 hr (BERL eta!., 1962a). It is
obvious from the calculations above that brain cortex can produce oxoglutarate at a
rate far in excess of that needed for glutamic acid synthesis if C02 fixation is not a
limiting reaction. These calculations are based on the assumption that the turnover
of the glutamic acid measured with 15 N ammonia approximates to the rate of turnover
of the carbon skeleton.
This set of experiments was undertaken mainly to answer the question, as set out
in the introduction, whether or not under the stress of increased glutamine formation
the rate of C02 fixation is accelerated and, therefore, this basic metabolic process
adapts itself to the metabolic environment in brain and may in part govern the rate of
the citric acid cycle. An answer to the first part of the question is suggested by a
comparison of the ,umoles of C02 incorporated from the tissue C02 into the metabolites of the TCA filtrate in the absence and presence of elevated ammonia levels
(Table 5). On the basis of this limited number of experiments it appears that in the
presence of ammonia more 14C atoms were incorporated into the compounds of the
TCA extract from brain cortex. Further analysis of the data (Table 6) shows that
the total amount of C02 incorporated appears to remain constant for aspartic and
glutamic acids but increases four-fold for glutamine, far beyond the actual increase
in concentration, which in extreme cases may double but on the average increases by
about 30 per cent. This observation in itself is a demonstration that in the presence
of elevated tissue ammonia there is an increased rate of C02 fixation and not merely
a redistribution of radioactivity fixed into oxaloacetate. Therefore, we are actually
not dealing with a preferential utilization of oxaloacetate for glutan1ine synthesis, but
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with the more rapid synthesis of oxaloacetate which is channelled into glutamine
formation without a significant disturbance of the oxaloacetate-aspartate relationship.
In absolute values, the increase in glutatnine counts does not decrease the ,umoles
of C02 unaccounted for, while it does so if calculated on a percentage basis. The
estimate of the increase in the rate of C02 fixation obtained in the experiments is
undoubtedly too low since we have no data on the amount of glutamine lost from the
brain into the cerebrospinal fluid and into the circulating blood.
TABLE 6.-RELATNE DISTRIBUTION OF FIXED 14 C0 2 INTO BRAIN GLUTAMIC ACID,
ASPARTIC ACID, AND GLUTAMINE

NH3 present
Experiment (22)

Experiment (23)

Experiment (26)

,umoles14 C/g
tissue

,umolesUC/g
tissue

~moles14 C/g

%

%

tissue

%

TCA extract

2·59

100

3·44

100

3·18

100

Glutamic acid
Aspartic acid
Glutamine
Total in amino acids
Unaccounted for

0·29
0·23
1·04
1·56
1·03

11·2
8·9
40·2
60·3
39·8

0·29
0·10
1·08
1·47
1·97

8·4
2·9
31·4
42·7
57·3

0·38
0·20
1·29
1·87
1· 31

11·9
6·3
40·6
58·8
41·2

p,moles14C/g
tissue

%

NH3 absent
Experiment (24)

Experiment (25)

Experiment (18)

TCA extract

2·33

100

1·69

100

1·63

Glutamic acid
Aspartic acid
Glutamine
Total in amino acids
Unaccounted for

0·28
0·23
0·28
0·79
1·54

12·0
9·9
12·0
33·9
66·1

0·26
0·18
0·27
0·71
0·98

15·4
10·6
16·0
42·0
58·0

0·31
0·56
0·32
1·19
0·44

100
19·0
34·4
19·6
73·0
27·0

Experiment (17)
1·72

100

0·23
0·21
0·13
0·57
1·15

13·4
12·2
7·6
33·1
66·9

GENERAL COMMENTS

The data presented in this paper support the conclusion that C02 fixation in the
mammalian brain is a process which responds to the change in the metabolic
environment. The rate of C02 fixation is increased when the tissue is exposed to a
metabolic stress, such as an elevated ammonia concentration, which results in an
increased synthesis of glutamine. Furthermore, the data show that C02 fixation is of
considerable significance in brain metabolism and not negligible as assumed by son1e
(BESSMAN, 1959); it plays an essential role in maintaining the concentration of
dicarboxylic acids in the citric acid cycle. The continuous removal of oxoglutarate
without replenishment would lead to a breakdown of the citric acid cycle and
consequently to a deficiency in the production of ATP. Although our data suggest
that C0 2 fixation may well replenish the intermediates of the citric acid cycle in case
of increased ammonia concentration in brain tissue, these acute experiments give no
answer as to the chronic effects of ammonia on the citric acid cycle. It should be kept
in mind that the increased glutamine synthesis utilizes pyruvate for this purpose
with a concomitant loss of energy as compared to that available from the complete·
oxidation of pyruvate. An increased glutan1ic acid synthesis may result also in an
increased NAD/NADH ratio (with a consequent decrease of oxygen utilization)
which may not be compatible with the operation of other vital biochemical processes
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responsible for the normal function of the nervous tissue. It will be necessary to
ascertain the rate of glucose utilization and its relation to C02 fixation in the presence
and absence of ammonia before definite conclusions can be drawn.
The present exploration of the probletn of C02 fixation uses an abnormal
experimental situation in which a large part of the fixed C02 is removed by the
increased synthesis of glutatnine. Without a drain on the intermediates of the citric
acid cycle, C02 fixation would correspond to the rate of decarboxylation and resynthesis of oxaloacetate without a net synthesis of the dicarboxylic acid. This would be
true whether or not the citric acid cycle operates at its normal or at an increased rate.
It is likely that in most physiological conditions C02 fixation will correspond to an
intermediate situation between the extreme one presented by the experiments in which
ammonia is administered and the one in which there is no drain on the citric acid
cycle intermediates. Such an intermediate situation may be represented by the control
experiments in which labelled bicarbonate was administered without ammonia. Our
experiments seem to indicate that the rate of C02 fixation may be coupled to that of
the citric acid cycle in the nervous system; this question is of particular importance
in view of the effect of C02 on the maintenance of function in the nervous system
(LORENTE de N 6, 1947).
Another aspect of the results of considerable general interest is the relationship of
oxoglutarate to glutamic acid metabolism. The closeness of the specific activities
of cerebral oxoglutarate and glutamic acid has been explained above by the action of
transaminases. Whether it occurs through transaminase action with participation
of oxaloacetate or by the half reaction (VELICK and VAVRA, 1962), both very rapid
processes, cannot be decided by our experiments lasting 3·5-25 min.
Our data offer an explanation along classical lines for the interesting results
obtained by CHAIN and his associates with brain tissue slices (CHAIN, CoHEN and
PocCHIARI, 1962; SELLINGER, CANTANZARO, CHAIN and PoccHIARI, 1962). These
authors found that the relative contribution of 14C02 to the respiratory C0 2 in the
presence of 14C labelled glutamic acid is independent of the amount of unlabelled
glucose added, i.e., despite an increased amount of C02 evolved, its specific activity
remained constant. On the other hand, the 14C02 furnished by labelled glucose is
diluted by added unlabelled glutamic acid. An explanation of these findings may be
seen not in a novel type of glutamic acid metabolism but rather in the rapid equilibrium between oxoglutarate and glutamic acid. As a result of the increased rate of
oxoglutarate metabolism from an increased concentration of glucose the labelled
glutamic acid may equilibrate with a larger pool of oxoglutarate per unit time, with
a corresponding increased contribution of 14C02 ; on the other hand, oxoglutarate
derived from unlabelled glutan1ate will decrease the specific activity of the expired
C02 in the presence of labelled glucose. Whereas this explanation removes the
necessity for the postulation of a novel mechanism of glutatnic acid metabolism, a
recent report appeared to give strong support to such a concept (CoHEN, SIMON,
BERRY and CHAIN, 1962). It was claimed that aspartic acid can be formed by a ydecarboxylation of glutamic acid. Experiments carried out to repeat this observation
were completely negative (see also HASLAM and KREBS, 1963). Therefore there
appears no reason to assume a metabolism of glutamic and aspartic acids by processes
other than those hitherto generally accepted. This conclusion, arrived at on the basis
of in vivo experiments, is in full accord with those reported recently by HASLAM and
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(1963) obtained with tissue slices. Since the postulate of metabolic compartments for the interpretation of our data is based throughout on the assumption of a
glutamic acid metabolism in brain closely related to the citric acid cycle, it was
important to evaluate the significance of proposed metabolic pathways in brain at
variance with the generally accepted ones.
KREBS

SUMMARY

The rate of fixation of carbon dioxide in vivo into aspartate, glutamate, oxoglutarate, and glutamine of cerebral cortex and liver in the absence and presence of
elevated concentrations of tissue ammonia was studied. The specific activities of the
isolated metabolites were related to the specific activity of the tissue C02 • It was
attempted to obtain an approximate steady state level of tissue 14C02 by maintaining
a constant isotope concentration in the venous and arterial blood through continuous
intravenous administration of NaH 14C03 •
1. In the absence of ammonia, aspartic acid achieved the highest specific activity
in both brain and liver; the specific activity of glutamine was greater than that of the
glutamic acid in the brain but the reverse was true in the liver.
2. In brain, in the absence of ammonia, the aspartic acid specific activity reached
a level 10- 25 per cent of that of the tissue C02 in experiments of 18 min duration,
while in liver the specific activity of aspartic acid approached a value twice that of
the tissue C02 •
3. In the presence of an increased level of ammonia in brain, the specific activity
of glutan1ine jncreased without a corresponding decrease in specific activities of
glutamic or aspartic acids. The amide achieved values 1·3 to 2·3 times that of the
aspartic acid and 4-5 times that of the glutamic acid.
The average concentration of glutamine in the brain cortex of the cat in the
control experiments was 5·8 ± 1·0 (s.n.),umoles/g (N = 7) which may be compared
with the value obtained in previous experiments, 5·3 + 0·6 #moles/g (N - 61) (BERL
et al., 1959, 1961b). For glutamic acid the respective values are 9·6 ± 1·0 #moles/g
(N = 10) and 9·6 ± 1·4 #molesjg (N = 62).
In the experiments in which atnmonia was administered (this paper) the average
glutamine concentration was found to be 7·7 ± 0·4 p,molesjg (N = 3). In previous
experiments in which ammonia was administered for various periods the average
concentration was 8·3 ± 0·8 ftiDOles/g (N - 8), (BERL et al., 1962a).
The average aspartic acid concentration in the present experiments was 2· 3 ± 0·4
fliDOles/g (N = 10). In previous experin1ents an average concentration of 2·5 ± 0·4
#moles/g (N = 23) of aspartic acid was found.
4. In liver the a-oxoglutarate had a lower specific activity than glutamate in
four of five experiments. In brain, in the experiments of 16- 18 min duration the
specific activity of the a-oxoglutarate was up to twice that of the glutamate but lower
than that of the glutamine.
5. The total amount of C0 2 incorporated into the metabolites of the non-protein
filtrate from brain tissue was increased in the presence of elevated levels of ammon ia.
6. In the presence of elevated levels of ammonia the total amounts of C02
incorporated into the glutamic and aspartic acids of brain cortex appeared to remain
constant but increased four-fold for glutamine.
It is concluded that, in brain, C02 fixation is of considerable significance and can
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respond with an increased rate to metabolic stress, such as is presented by elevated
tissue ammonia.
In addition, the data support the conclusion that in brain tissue the glutamic
acid-glutamine system is compartmentalized; they also suggest the compartmentalization of a-oxoglutarate metabolism in both brain and liver.
Acknowledgment-We should like to thank Mr. MORRIS CHEDEKEL for his excellent technical
assistance during the course of this work.
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